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Loss of consciousness and falling are the key features of syncope. Common accompaniments include tonic and myoclonic
muscle activity, eye deviations, automatisms, vocalizations and hallucinations that may render the distinction from epileptic
seizures difficult. The frequently increased levels of serum prolactin (SPRL) were observed immediately after generalized and
complex partial seizures. Presumably, the hormone release is caused by the propagation of epileptic activity, usually from the
temporal lobe to the hypothalamic pituitary axis. Numerous reports have demonstrated that the post-ictal SPRL level may be
used to differentiate between epileptic and syncopal, non-epileptic attacks. In order to confirm the hypothesis, the SPRL levels
were measured in patients with compex partial seizures (CPS) and patients with vaso-vagal syncopal attacks (VVS). The SPRL
levels were prospectively measured for each patient as soon as possible after the event (within 1 hour), then 1 hour after the first
determination and finally blood was sampled 24 hours later. During the study period (18 months), 18 patients with CPS and
15 patients with VVS were investigated in total. The mean values of SPRL levels in both groups were increased immediately
after the event (CPS group: 1142305 mIU/l; VVS group: 874208 mIU/l). The elevated SPRL levels were found in 14 (78%)
patients immediately after CPS and in 9 (60%) patients immediately after VVS. After examining the results of the present study
we conclude that the elevated serum prolactin level after an epileptic attack is of no significant value in differential diagnosis
between epileptic and vaso-vagal syncopal attacks.
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Differential diagnosis between epileptic seizures, espe-
cially between complex partial seizures (CPS), pseudo-
seizures and complicated syncope is a common diag-
nostic problem. The variety of ways in which seizures
and syncopal attacks are expressed has made their
diagnosis difficult, particularly because the patient fre-
quently cannot describe either the nature or the duration
of events. Investigations such as electroencephalogram
(EEG) may aid diagnosis, but are never diagnostic in
isolation. Reliance solely on EEG patterns can some-
times lead to both false positive, and false negative
diagnoses.
Thus, the diagnosis of epilepsy on the basis of typical
signs, symptoms, or routine laboratory tests is not an
easy task. Diagnosis is further complicated by the close
resemblance of some types of seizures to a variety of
other neurological, psychiatric, and medical disorders.
k E-mail: ivo.lusic@st.tel.hr1059–1311/99/040218 + 05 $12.00/0Prolactin elevation has been described follow-
ing generalized tonic–clonic and complex partial
seizures1–8. Consequently, in the last few years, the
determination of prolactin serum levels (SPRL), im-
mediately after the attack, has been used as an ancillary
investigation in differentiating between seizures and
pseudo-seizures2, 5, 8. The same diagnostic clue was
proposed for distinguishing between a seizure and
complicated syncope9–11. To test this hypothesis, we
examined the dynamics of serum prolactin concen-
trations after the epileptic attack and after postural
vaso-vagal syncope.
Materials and Methods
Patients were recruited from the population attending
the Department of Neurology at the Clinical Hospital
Split, seeking emergency treatment after unexpected
syncopal attacks or after grand mal seizures. All pa-c© 1999 BEA Trading Ltd
Serum prolactin after seizure 219tients were admitted to the Department. Two groups
of subjects were included in the investigation; those
experiencing complex partial seizures and those expe-
riencing vaso-vagal syncopal attacks (VVS):
CPS group: 18 female patients (mean age 28:25:8
years), with an established diagnosis of epilepsy and
seen immediately after a complex partial seizure attack.
All patients were on medication (carbamazepine 14,
valproic acid 6, metilphenobarbitone 3, lamotrigine 1,
vigabatrin 1).
VVS group: 15 female patients (mean age 32:45:5
years) examined immediately after typical postural
vaso-vagal syncope attack, but otherwise healthy12.
Those patients with a suspected or proven cardiac aetio-
logy for syncope, or autonomic failure, were excluded
from the study.
Dynamics of the serum prolactin concentrations were
investigated as follows: serum prolactin levels were as-
sessed as soon as possible after the event (fainting or
seizure) — within 60 minutes following the episode
(SPRL1), then 60 minutes after the first sample was
taken (SPRL2), and the final determination of the pro-
lactin level was made 24 hours later (SPRL3).
Blood samples for serum prolactin concentrations
were drawn from an antecubital vein. Aliquots were
centrifuged and the serum separated and stored at
−60C until assayed. Prolactin concentrations were
measured using a commercial radioimmunoassay
method (Prolactin-IRMA, manufactured by IBL, Ham-
burg, Germany). Values above 630 mIU/L (26 ng/ml)
for women under 45 years were reported as elevated.
Statistical analysis: the Mann–Whitney U-test was
used in order to compare unpaired samples because of
the assumption that prolactin values were not normally
distributed. The Wilcoxon test was used for comparing
paired samples.
Results
Figure 1 and Fig. 2 present the individual values of
serum prolactin levels for the first two determinations
(SPRL1 and SPRL2) in both groups of patients. In the
CPS group SPRL1 was elevated in 14 (78%) patients,
and SPRL2 was elevated in only 2 (11%) patients. In the
VVS group SPRL1 was elevated in 9 (60%) patients,
and SPRL2 in only 1 (6.5%) patient. In both of the
groups, SPRL3 remained within the normal reference
range limits (under 630 mIU/l) in all patients.
Figure 3 presents the mean values of serum prolactin
levels (MSPRL) in both groups of patients for each
study period. There was an obvious higher mean serum
prolactin level during the first sampling (MSPRL1) in
the CPS group in relation to the VVS group (Mann–
Whitney test: Z D 3:074; P D 0:002), but mean serum
prolactin values were elevated, compared with normallaboratory range, in both groups of patients. The differ-
ences in the mean serum prolactin levels between the
CPS and the VVS group for the samples taken 1 hour
(MSPRL2), and 24 hours later (MSPRL3), did not reach
statistical significance (Mann–Whitney test: MSPRL2
−Z D 1:61; P D 0:11; MSPRL3 −Z D 0:158;
P D 0:17). In both groups, there was a significant fall
from MSPRL1 values to MSPRL2 values (Wilcoxon
test: CPS group −Z D 2:73; P D 0:006; VVS group
−Z D 2:41; P D 0:012).
Discussion
A few disorders mimic epileptic seizures, especially
complex partial seizures. We are often witness to
‘seizures that do not look like seizures’. The most
common imitators of seizures include syncope, cere-
brovascular disorders, migraine, sleep and movement
disorders, endocrine dysfunction, delirium, hyperven-
tilation, dizziness, and vertigo. Clinical examination,
physiological and biochemical tests can be used to
differentiate the imitative conditions from epileptic
seizures. Most of the features discussed raise impor-
tant medical issues, because the urgency and course
of treatment are quite different depending on the di-
agnosis. In addition to medical mimicry, malingering,
episodic dyscontrol, psychogenic seizures, and pseudo-
seizures are also frequently misdiagnosed as epileptic
seizures.
New insights into the phenomenology of syncope
(transient cerebral hypoxia) have been gained from
video analysis of experimentally induced syncope.
Common elements of syncope include multifocal and
generalized myoclonus, tonic body extension, automa-
tisms, vocalizations, eye deviations and hallucina-
tions13–15. Thus, it is not the presence or absence of
these features but their specific character which distin-
guishes syncope from epileptic seizures. Other clues
for differential diagnosis include precipitating factors,
premonitory symptoms and post-ictal events, such as
tongue bites and post-ictal confusion, which has been
identified as the single most powerful factor discrimin-
ating syncope from epileptic seizures. In contrast, in-
continence and head injury are common in both condi-
tions. In rare cases, hypoxic and epileptic mechanisms
may interact within one attack. Although a detailed
history of an event may be helpful in most cases, the
clinician often relies on ancillary test results to reach a
diagnosis.
Serum levels of prolactin may increase as a conse-
quence of some kind of epileptic seizures (grand mal
and complex partial seizures), but the increase is tran-
sient. Usually, prolactin blood levels increase within
30 minutes post-ictally after epileptic seizures and re-
turn to normal values within 1 hour4, 5, 7, 8. Seizure-
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Fig. 1: Serum prolactin values (mIU/l) in patients with complex partial seizures .n D 18/: immediately after the attack (SPRL1) and
60 minutes later (SPRL2).
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Fig. 2: Serum prolactin values (mIU/l) in patients with vaso-vagal syncope .n D 15/: immediately after the attack (SPRL1) and
60 minutes later (SPRL2).
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Fig. 3: Mean values of serum prolactin levels (MSPRL) in patients with complex partial seizure (CPS) and patients with vaso-vagal
syncope (VVS) (mIU/l): MSPRL1, values observed immediately after the attack; MSPRL2, values observed 60 minutes after first
determination; MSPRL3, values observed 24 hours later. *P D NS; **P D 0:002.
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ing prolactin levels. After shorter seizure-free inter-
vals, prolactin responses are reduced. This suggests
that the amount of releasable prolactin is limited, de-
pleted by seizures, or perhaps inhibited by prolactin
feedback7. There is no significant influence of differ-
ent antiepileptic drugs (sodium valproate, phenobarbi-
tal, carbamazepine) on serum prolactin levels16.
The hormone release is caused by the propagation
of epileptic activity, probably from the temporal lobe
to the hypothalamic pituitary axis. Due to the intensity
of the epilepsy after discharge, a rise in serum pro-
lactin levels is seen, similar to that of 70% of complex
partial seizures. Prolactin usually fails to rise after psy-
chogenic seizures; therefore, post-ictal prolactin lev-
els can be used to differentiate between epileptic and
psychogenic seizures. However, a subclassification of
epileptic seizures by means of prolactin measurement
is not possible11.
Prolactin levels are highly dependent on how quickly
a blood sample is obtained after the event, the physio-
logical severity of the event (localized or generalized
in the brain), and the origin of the electrical discharge
(e.g. frontal or temporal). The fact that prolactin lev-
els often do not rise after seizures originating in the
frontal lobes does not help to clarify these difficult-to-
diagnose events. The lack of generalizability of such
data prevents prolactin levels from being considered as
a standard tool for diagnosis15.
Numerous investigators have found that serum pro-
lactin levels increase after tonic–clonic and complex
partial seizures, but the effect of syncope on prolactin
levels has been little studied. Several authors have re-
ported that elevated serum prolactin levels could be
useful in differentiating epileptic seizures from syn-
copal attacks2, 3, 6, 8–11, but there are a few opposing
conclusions17–20.
The current study was conducted to test whether
vaso-vagal syncope releases prolactin in serum, and
also to investigate possible differences in serum pro-
lactin dynamics between syncopal and epileptic at-
tacks. The results obtained demonstrate that serum
prolactin concentrations rise after vaso-vagal syncope,
reaching a maximum within the first 60 minutes after
an event. Consequently, our results do not support the
theory that elevated prolactin levels could be helpful
as an ancillary investigation in differentiating between
epileptic (complex partial seizure) and vaso-vagal syn-
copal attacks. In our study, elevation of prolactin levels
after the epileptic attacks was more robust than com-
pared with the serum prolactin rise in patients with
syncopal attacks, but this difference is insufficient to
modify our conclusion about the usefulness of this test.
Patients with postural vaso-vagal syncope demon-
strated numerous ‘exaggerated’ neurohumoral re-
sponses to syncope. Differential changes in plasmalevels of epinephrine, renin, endothelin, vasopressin,
cortisol, prolactin, beta-endorphins, and substance P
have been reported by some investigators either prior
to or during a syncopal episode in patients with vaso-
vagal syncope. The precise pathophysiological signifi-
cance of these measurements is unknown at the present
time21, 22.
Conclusions
Although the current study does not clarify whether
it was the syncope itself, or the emotional stress (or
both) that caused the prolactin elevations after synco-
pal attacks, it implies that measurement of this hor-
mone will not help the clinician to distinguish between
seizures and vaso-vagal syncopal attacks. Determina-
tion of serum prolactin can still be regarded as a valu-
able aid in the differential diagnosis between epileptic
and psychogenic seizures.
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